ceRNA Network Dynamics in Inflammatory Bowel Disease: The LncRNA–miRNA–mRNA Axis in Intestinal Homeostasis and Inflammation
Cell Biochemistry and Biophysics · 2025
DOI: 10.1007/s12013-025-01951-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Rofayda Ihab und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genome Mapping Department, Agricultural Genetic Engineering Research Institute (AGERI), Agricultural Research Center (ARC), Giza, 12619, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Inflammatory Bowel Diseases, RNA, Messenger. Die Arbeit nennt 185 Literaturangaben.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), which encompasses Crohn’s disease (CD) and ulcerative colitis (UC), is an inflammatory condition influenced by genetic, environmental, microbial, and immunological factors. Recent studies emphasize the significant roles of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) as essential components of competing endogenous RNA (ceRNA) networks in IBD. Non-coding RNAs (ncRNAs) are often dysregulated in IBD, affecting inflammation, immune responses, and the integrity of the epithelial barrier. lncRNA–miRNA interactions function as regulatory centers that influence signaling pathways crucial for sustaining intestinal homeostasis. Disruptions in lncRNA–miRNA interactions damage epithelial integrity, promote inflammation, and drive disease progression. These non-coding RNAs’ stability and specificity in biological fluids make them potential non-invasive biomarkers for early diagnosis and disease monitoring. Targeting lncRNA–miRNA interactions present a new therapeutic approach to restore intestinal barrier integrity and maintain immunological balance. Despite recent advancements, further research is needed to translate these findings into clinically applicable diagnostic tools and therapies. This review provides an overview of lncRNA–miRNA–mRNA interactions in IBD, emphasizing their significance as essential components of ceRNA networks. Also, this review explores how crosstalk modulates immune regulation and epithelial function, evaluating the potential of these interactions as diagnostic and therapeutic targets. It highlights ceRNA networks and incorporates spatial omics technologies, setting it apart from previous reviews.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genome Mapping Department, Agricultural Genetic Engineering Research Institute (AGERI), Agricultural Research Center (ARC), Giza, 12619, Egypt.
- Biotechnology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo, 11562, Egypt.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab, 21934, Egypt.
- Department of Chemistry, Faculty of Science, Cairo University, 12613, Giza, Egypt.
- Genome Mapping Department, Agricultural Genetic Engineering Research Institute (AGERI), Agricultural Research Center (ARC), Giza, 12619, Egypt. matia@matia.org.
Zitieren
APA
Ihab, R., Saber, M. M., Fouad, A. S., El-Sherif, A. A., & Atia, M. A. M. (2025). ceRNA Network Dynamics in Inflammatory Bowel Disease: The LncRNA–miRNA–mRNA Axis in Intestinal Homeostasis and Inflammation. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-025-01951-8
Vancouver
Ihab R, Saber MM, Fouad AS, El-Sherif AA, Atia MAM. ceRNA Network Dynamics in Inflammatory Bowel Disease: The LncRNA–miRNA–mRNA Axis in Intestinal Homeostasis and Inflammation. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-025-01951-8
BibTeX
@article{Ihab2025,
author = {Ihab, Rofayda and Saber, Mona M and Fouad, Ahmed S and El-Sherif, Ahmed A and Atia, Mohamed A M},
title = {ceRNA Network Dynamics in Inflammatory Bowel Disease: The LncRNA–miRNA–mRNA Axis in Intestinal Homeostasis and Inflammation},
journal = {Cell Biochemistry and Biophysics},
year = {2025},
doi = {10.1007/s12013-025-01951-8}
}
EUVIMED